CD4+ T Cell Fate in Glomerulonephritis: A Tale of Th1, Th17, and Novel Treg Subtypes

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Krebs, Christan F ^a   Steinmetz, Oliver M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR ROR GAMMA T; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL FATE; CELL HETEROGENEITY; CELL LINEAGE; CELL PLASTICITY; CELL TRANSDIFFERENTIATION; CYTOKINE RELEASE; EFFECTOR CELL; GLOMERULONEPHRITIS; IMMUNE SYSTEM; INFLAMMATION; KIDNEY PARENCHYMA; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; CELL DIFFERENTIATION; HUMAN; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; GLOMERULONEPHRITIS; HUMANS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84999622386     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/5393894     Document Type: Article

References (69)

1. W. G. Couser, "Basic and translational concepts of immunemediated glomerular diseases, " Journal of the American Society of Nephrology, vol. 23, no. 3, pp. 381-399, 2012.
2. C. Kurts, U. Panzer, H.-J. Anders, A. J. Rees, "The immune system and kidney disease: basic concepts and clinical implications, " Nature Reviews Immunology, vol. 13, no. 10, pp. 738-753, 2013.
3. P. G. Tipping and S. R. Holdsworth, "T cells in glomerulonephritis, " Springer Seminars in Immunopathology, vol. 24, no. 4, pp. 377-393, 2003.
4. R. K. S. Phoon, A. R. Kitching, D. Odobasic, L. K. Jones, T. J. Semple, S. R. Holdsworth, "T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis, " Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 477-485, 2008.
5. H.-J. Paust, J.-E. Turner, O. M. Steinmetz et al., "The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis, " Journal of the American Society of Nephrology, vol. 20, no. 5, pp. 969-979, 2009.
6. J.-E. Turner, H.-J. Paust, O. M. Steinmetz, U. Panzer, "The Th17 immune response in renal inflammation, " Kidney International, vol. 77, no. 12, pp. 1070-1075, 2010.
7. O. M. Steinmetz, S. A. Summers, P. Y. Gan, T. Semple, S. R. Holdsworth, A. R. Kitching, "The Th17-defining transcription factor RORgammat promotes glomerulonephritis, " Journal of theAmerican Society ofNephrology, vol. 22, no. 3, pp. 472-483, 2011.
8. S. Hünemörder, J. Treder, S. Ahrens et al., "TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis, "The Journal of Pathology, vol. 237, no. 1, pp. 62-71, 2015.
9. U. Panzer, O. M. Steinmetz, H.-J. Paust et al., "Chemokine receptorCXCR3mediatesTcell recruitment and tissue injury in nephrotoxic nephritis in mice, " Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2071-2084, 2007.
10. O. M. Steinmetz, J.-E. Turner, H.-J. Paust et al., "CXCR3 mediates renalTh1 and Th17 immune response inmurine lupus nephritis, "The Journal of Immunology, vol. 183, no. 7, pp. 4693-4704, 2009.
11. J.-E. Turner, H.-J. Paust, O. M. Steinmetz et al., "CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis, " Journal of the American Society of Nephrology, vol. 21, no. 6, pp. 974-985, 2010.
12. H.-J. Paust, A. Ostmann, A. Erhardt et al., "Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis, " Kidney International, vol. 80, no. 2, pp. 154-164, 2011.
13. J. D. Ooi, S. L. Snelgrove, D. R. Engel et al., "Endogenous foxp3+ T-regulatory cells suppress anti-glomerular basement membrane nephritis, " Kidney International, vol. 79, no. 9, pp. 977-986, 2011.
14. O. M. Steinmetz, J.-E. Turner, U. Panzer, "Staying on top of things right from the start: the obsessive-compulsive disorder of regulatory T cells, " Journal of the American Society of Nephrology, vol. 21, no. 1, pp. 6-7, 2010.
15. D. Odobasic, P.-Y. Gan, S. A. Summers et al., "Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice, " The American Journal of Pathology, vol. 179, no. 3, pp. 1188-1198, 2011.
16. H.-J. Paust, J.-E. Turner, J.-H. Riedel et al., "Chemokines play a critical role in the cross-regulation of Th1 andTh17 immune responses in murine crescentic glomerulonephritis, " Kidney International, vol. 82, no. 1, pp. 72-83, 2012.
17. M. A. Kluger, M. C. Meyer, A. Nosko et al., "ROR+Foxp3+ cells are an independent bifunctional regulatory T cell lineage and mediate crescentic GN, " Journal of the American Society of Nephrology, vol. 27, no. 2, pp. 454-465, 2016.
18. D. Bending, H. De La Pena, M. Veldhoen et al., "Highly purified Th17 cells from BDC2. 5NOD mice convert into Th1-like cells in NOD/SCID recipient mice, "The Journal of Clinical Investigation, vol. 119, no. 3, pp. 565-572, 2009.
19. K. Hirota, J. H. Duarte, M. Veldhoen et al., "Fate mapping of IL-17-producing T cells in inflammatory responses, " Nature Immunology, vol. 12, no. 3, pp. 255-263, 2011.
20. S. N. Harbour, C. L. Maynard, C. L. Zindl, T. R. Schoeb, C. T. Weaver, "Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 22, pp. 7061-7066, 2015.
21. A. Jäger, V. Dardalhon, R. A. Sobel, E. Bettelli, V. K. Kuchroo, "Th1, Th17, Th9 effector cells induce experimental autoimmune encephalomyelitiswith different pathological phenotypes, " Journal of Immunology, vol. 183, no. 11, pp. 7169-7177, 2009.
22. H. J. Koenen, R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. Boots, I. Joosten, "Human CD25Foxp3 regulatory T cells differentiate into IL-17-producing cells, " Blood, vol. 112, no. 6, pp. 2340-2352, 2008.
23. Y. K. Lee, H. Turner, C. L. Maynard et al., "Late developmental plasticity in the T helper 17 lineage, " Immunity, vol. 30, no. 1, pp. 92-107, 2009.
24. M. Löhning, A. N. Hegazy, D. D. Pinschewer et al., "Longlived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors, " Journal of Experimental Medicine, vol. 205, no. 1, pp. 53-61, 2008.
25. K. Lüthje, A. Kallies, Y. Shimohakamada et al., "The development and fate of follicular helper T cells defined by an IL-21 reportermouse, "Nature Immunology, vol. 13, no. 5, pp. 491-498, 2012.
26. X. O. Yang, R. Nurieva, G. J. Martinez et al., "Molecular antagonism and plasticity of regulatory and inflammatory T cell programs, " Immunity, vol. 29, no. 1, pp. 44-56, 2008.
27. H. Ahlfors, P. J. Morrison, J. H. Duarte et al., "IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection, " Journal of Immunology, vol. 193, no. 9, pp. 4602-4613, 2014.
28. C. Wilhelm, K. Hirota, B. Stieglitz et al., "An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation, "Nature Immunology, vol. 12, no. 11, pp. 1071-1077, 2011.
29. X. Zhou, S. L. Bailey-Bucktrout, L. T. Jeker et al., "Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, " Nature Immunology, vol. 10, no. 9, pp. 1000-1007, 2009.
30. K. Hirota, J.-E. Turner, M. Villa et al., "Plasticity of TH 17 cells in Peyer's patches is responsible for the induction of T celldependent IgA responses, " Nature Immunology, vol. 14, no. 4, pp. 372-379, 2013.
31. N. Gagliani, M. C. A. Vesely, A. Iseppon et al., "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation, " Nature, vol. 523, no. 7559, pp. 221-225, 2015.
32. J. T. Gaublomme, N. Yosef, Y. Lee et al., "Single-cell genomics unveils critical regulators of Th17 cell pathogenicity, " Cell, vol. 163, no. 6, pp. 1400-1412, 2015.
33. C. Wang, N. Yosef, J. Gaublomme et al., "CD5L/AIMregulates lipid biosynthesis and restrains Th17 cell pathogenicity, " Cell, vol. 163, no. 6, pp. 1413-1427, 2015.
34. S. Becattini, D. Latorre, F. Mele et al., "Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines, " Science, vol. 347, no. 6220, pp. 400-406, 2015.
35. A. Han, J. Glanville, L. Hansmann, M. M. Davis, "Linking T-cell receptor sequence to functional phenotype at the singlecell level, "Nature Biotechnology, vol. 32, no. 7, pp. 684-692, 2014.
36. M. DuPage and J. A. Bluestone, "Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease, " Nature Reviews Immunology, vol. 16, no. 3, pp. 149-163, 2016.
37. N. Komatsu, M. E. Mariotti-Ferrandiz, Y. Wang, B. Malissen, H. Waldmann, S. Hori, "Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1903-1908, 2009.
38. N. Komatsu, K. Okamoto, S. Sawa et al., "Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis, " Nature Medicine, vol. 20, no. 1, pp. 62-68, 2014.
39. D. Valmori, C. Raffin, I. Raimbaud, M. Ayyoub, "Human RORgammat+TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19402-19407, 2010.
40. E. Yurchenko, M. T. Shio, T. C. Huang et al., "Inflammationdriven reprogramming of CD4+Foxp3+ regulatory T cells into pathogenicTh1/Th17 T effectors is abrogated by mTOR inhibition in vivo, " PLoS ONE, vol. 7, no. 4, Article ID e35572, 2012.
41. A. R. Kitching and S. R. Holdsworth, "The emergence of Th17 cells as effectors of renal injury, " Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 235-238, 2011.
42. S. A. Summers, O. M. Steinmetz, M. Li et al., "Th1 andTh17 cells induce proliferative glomerulonephritis, " Journal of the American Society of Nephrology, vol. 20, no. 12, pp. 2518-2524, 2009.
43. C. Tulone, A. Giorgini, S. Freeley, A. Coughlan, M. G. Robson, "Transferred antigen-specific TH17 but not TH1 cells induce crescentic glomerulonephritis in mice, " The American Journal of Pathology, vol. 179, no. 6, pp. 2683-2690, 2011.
44. C. F. Krebs, J. E. Turner, H. J. Paust et al., "Plasticity ofTh17 cells in autoimmune kidney diseases, " The Journal of Immunology, vol. 197, no. 2, pp. 449-457, 2016.
45. E. Esplugues, S. Huber, N. Gagliani et al., "Control of TH17 cells occurs in the small intestine, " Nature, vol. 475, no. 7357, pp. 514-518, 2011.
46. S. Huber, N. Gagliani, E. Esplugues et al., "Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner, " Immunity, vol. 34, no. 4, pp. 554-565, 2011.
47. J. H. Duarte, S. Zelenay, M.-L. Bergman, A. C. Martins, J. Demengeot, "NaturalTreg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions, " European Journal of Immunology, vol. 39, no. 4, pp. 948-955, 2009.
48. S. L. Bailey-Bucktrout, M. Martinez-Llordella, X. Zhou et al., "Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response, " Immunity, vol. 39, no. 5, pp. 949-962, 2013.
49. T. Miyao, S. Floess, R. Setoguchi et al., "Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells, " Immunity, vol. 36, no. 2, pp. 262-275, 2012.
50. Y. P. Rubtsov, R. E. Niec, S. Josefowicz et al., "Stability of the regulatory T cell lineage in vivo, " Science, vol. 329, no. 5999, pp. 1667-1671, 2010.
51. S. Hori, "Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells, " Immunological Reviews, vol. 259, no. 1, pp. 159-172, 2014.
52. A. Chaudhry, D. Rudra, P. Treuting et al., "CD4+ regulatory T cells control TH17 responses in a stat3-dependent manner, " Science, vol. 326, no. 5955, pp. 986-991, 2009.
53. M. A. Koch, G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, D. J. Campbell, "The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation, "Nature Immunology, vol. 10, no. 6, pp. 595-602, 2009.
54. M. Lochner, L. Peduto, M. Cherrier et al., "In vivo equilibriumof proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORt+ T cells, " The Journal of Experimental Medicine, vol. 205, no. 6, pp. 1381-1393, 2008.
55. D. Q. Tran, H. Ramsey, E. M. Shevach, "Induction of FOXP3 expression in naive human CD4+FOXP3-T cells by T-cell receptor stimulation is transforming growth factor-dependent but does not confer a regulatory phenotype, " Blood, vol. 110, no. 8, pp. 2983-2990, 2007.
56. J. Wang, A. Ioan-Facsinay, E. I. H. van der Voort, T. W. J. Huizinga, R. E. M. Toes, "Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells, " European Journal of Immunology, vol. 37, no. 1, pp. 129-138, 2007.
57. M. A. Kluger, M. Luig, C. Wegscheid et al., "Stat3 programs Th17-specific regulatory T cells to control GN, " Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1291-1302, 2014.
58. M. A. Kluger, S. Melderis, A. Nosko et al., "Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus, " Kidney International, vol. 89, no. 1, pp. 158-166, 2016.
59. H. J. Paust, J. H. Riedel, C. F. Krebs et al., "CXCR3+ regulatory T cells control TH1 responses in crescentic GN, " Journal of the American Society of Nephrology, vol. 27, no. 7, pp. 1933-1942, 2016.
60. A. Nosko, M. A. Kluger, P. Diefenhardt et al., "T-Bet enhances regulatory T cell fitness and directs control ofTh1 responses in crescentic GN, " Journal of the American Society of Nephrology, 2016.
61. D. J. Campbell and M. A. Koch, "Phenotypical and functional specialization of FOXP3+ regulatory T cells, " Nature Reviews Immunology, vol. 11, no. 2, pp. 119-130, 2011.
62. A. Chaudhry and A. Y. Rudensky, "Control of inflammation by integration of environmental cues by regulatory T cells, " The Journal of Clinical Investigation, vol. 123, no. 3, pp. 939-944, 2013.
63. A. Liston and D. H. D. Gray, "Homeostatic control of regulatory T cell diversity, " Nature Reviews Immunology, vol. 14, no. 3, pp. 154-165, 2014.
64. C. Ohnmacht, J.-H. Park, S. Cording et al., "The microbiota regulates type 2 immunity through RORt(+) T cells, " Science, vol. 349, no. 6251, pp. 989-993, 2015.
65. E. Sefik, N. Geva-Zatorsky, S. Oh et al., "Individual intestinal symbionts induce a distinct population of ROR+ regulatory T cells, " Science, vol. 349, no. 6251, pp. 993-997, 2015.
66. A. M. Pesenacker, D. Bending, S. Ursu, Q. Wu, K. Nistala, L. R. Wedderburn, "CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines, " Blood, vol. 121, no. 14, pp. 2647-2658, 2013.
67. N. R. Blatner, M. F. Mulcahy, K. L. Dennis et al., "Expression of RORgammat marks a pathogenic regulatory T cell subset in human colon cancer, " Science TranslationalMedicine, vol. 4, no. 164, Article ID 164ra159, 2012.
68. M. Ayyoub, F. Deknuydt, I. Raimbaud et al., "Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORt, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8635-8640, 2009.
69. B. H. Yang, S. Hagemann, P. Mamareli et al., "Foxp3+ T cells expressing RORt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation, "Mucosal Immunology, vol. 9, no. 2, pp. 444-457, 2015.